Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-18F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas

Nuclear Medicine Communications

Volumn 35, Issue 3, 2014, Pages 245-251

  Zhang, Ke ^a   Langen, Karl Josef ^a,b   Neuner, Irene ^a,b   Stoffels, Gabriele ^a   Filss, Christian ^a   Galldiks, Norbert ^a,c   Tellmann, Lutz ^a   Rota Kops, Elena ^a   Coenen, Heinz H ^a   Herzog, Hans ^a   Shah, Nadim J ^a,b  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Arterial spin labelling; cerebral glioma; dynamic 18F FET PET; kinetics; regional cerebral blood flow

Indexed keywords

FLUORINE 18; O 2 FLUOROETHYLTYROSINE F 18; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; DRUG UPTAKE; FEMALE; FLOW KINETICS; GLIOMA; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PET-MRI SCANNER; POSITRON EMISSION TOMOGRAPHY; RADIOLOGICAL PARAMETERS; SPIN LABELING; TIME ACTIVITY CURVE; TUMOR TO BRAIN RATIO; YOUNG ADULT;

ADULT; AGED; BIOLOGICAL TRANSPORT; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; FEMALE; GLIOMA; HUMANS; KINETICS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TYROSINE;

EID: 84893811455     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0000000000000036     Document Type: Article

References (31)

1. 18F-fluoroethyl)- L-tyrosine PET and MRI in low-grade glioma. J Nucl Med 2007; 48:519-527.
2. 18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 2005; 128:678-687.
3. 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med 2006; 47: 393-403.
4. Popperl G, Kreth FW, Mehrkens JH, Herms J, Seelos K, Koch W, et al. FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging 2007; 34:1933-1942.
5. 18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy. Clin Nucl Med 2011; 36:841-847.
6. Galldiks N, Stoffels G, Filss CP, Piroth MD, Sabel M, Ruge MI, et al. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med 2012; 53:1367-1374.
7. Galldiks N, Rapp M, Stoffels G, Fink GR, Shah NJ, Coenen HH, et al. Response assessment of bevacizumab in patients with recurrent malignant glioma using [(18)F]fluoroethyl-L-tyrosine PET in comparison to MRI. Eur J Nucl Med Mol Imaging 2013; 40:22-33.
8. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001; 42:432-445.
9. 11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003; 30:868-873.
10. Stockhammer F, Plotkin M, Amthauer H, van Landeghem FK, Woiciechowsky C. Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas. J Neurooncol 2008; 88:205-210.
11. Ye FQ, Berman KF, Ellmore T, Esposito G, van Horn JD, Yang Y, et al. H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med 2000; 44:450-456.
12. Ludemann L, Warmuth C, Plotkin M, Forschler A, Gutberlet M, Wust P, Amthauer H. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. Eur J Radiol 2009; 70:465-474.
13. 18F fluoroethyl-L-tyrosine. Appl Radiat Isot 2002; 57: 853-856.
14. Schlemmer HP, Pichler BJ, Schmand M, Burbar Z, Michel C, Ladebeck R, et al. Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 2008; 248:1028-1035.
15. Herzog H, Langen KJ, Weirich C, Rota Kops E, Kaffanke J, Tellmann L, et al. High resolution brainPET combined with simultaneous MRI. Nuklearmedizin 2011; 50:74-82.
16. Rota Kops ER, Herzog H. Template based attenuation correction for PET in MR-PET scanners. IEEE Nuclear Science Symposium Conference Record 2008 (NSS'08); 19-25 October 2008; Dresden, Germany: IEEE 3786-3789.
17. Michel C, Liu X, Sanabria S, Lonneux M, Sibomana M, Bol A, et al. Weighted schemes applied to 3D-OSEM reconstruction in PET. IEEE Nuclear Science Symposium Conference Record 1999 (NSS 1999); 24-30 October 1999; Seattle, Washington, USA: IEEE 1152-1157.
18. Wong EC, Buxton RB, Frank LR. Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II). Magnet Reson Med 1998; 39:702-708.
19. Gunther M, Oshio K, Feinberg DA. Single-shot 3D imaging techniques improve arterial spin labeling perfusion measurements. Magn Reson Med 2005; 54:491-498.
20. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998; 40:383-396.
21. Pietrzyk U, Herholz K, Schuster A, von Stockhausen HM, Lucht H, Heiss WD. Clinical applications of registration and fusion of multimodality brain images from PET, SPECT, CT, and MRI. Eur J Radiol 1996; 21: 174-182.
22. Herholz K, Langen KJ, Schiepers C, Mountz JM. Brain tumors. Semin Nucl Med 2012; 42:356-370.
23. 18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2006; 33:287-294.
24. Langen KJ, Tatsch K, Grosu AL, Jacobs AH, Weckesser M, Sabri O. Diagnostics of cerebral gliomas with radiolabeled amino acids. Dtsch Arztebl Int 2008; 105:55-61.
25. 18F]fluoroethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging 2005; 32:422-429.
26. Stiver SI. Angiogenesis and its role in the behavior of astrocytic brain tumors. Front Biosci 2004; 9:3105-3123.
27. 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma. J Nucl Med 2013; 54:229-235.
28. Wyss MT, Hofer S, Hefti M, Bartschi E, Uhlmann C, Treyer V, Roelcke U. Spatial heterogeneity of low-grade gliomas at the capillary level: a PET study on tumor blood flow and amino acid uptake. J Nucl Med 2007; 48: 1047-1052.
29. Miyagawa T, Oku T, Uehara H, Desai R, Beattie B, Tjuvajev J, Blasberg R. 'Facilitated' amino acid transport is upregulated in brain tumors. J Cerebr Blood F Met 1998; 18:500-509.
30. 18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 1999; 40:1367-1373.
31. Neuner I, Kaffanke JB, Langen KJ, Kops ER, Tellmann L, Stoffels G, et al. Multimodal imaging utilising integrated MR-PET for human brain tumour assessment. Eur Radiol 2012; 22:2568-2580.